本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inhibrx Biosciences

90.53
-4.4800-4.72%
盘前:90.970.4400+0.49%09:04 EDT
成交量:21.61万
成交额:1,981.24万
市值:13.28亿
市盈率:-10.20
高:96.10
开:94.03
低:90.00
收:95.01
52周最高:155.29
52周最低:28.16
股本:1,467.12万
流通股本:858.89万
量比:1.21
换手率:2.52%
股息:- -
股息率:- -
每股收益(TTM):-8.8768
每股收益(LYR):-9.0434
净资产收益率:-1773.60%
总资产收益率:-43.61%
市净率:-25.07
市盈率(LYR):-10.01

数据加载中...

2026/09/28

重要事件披露

Form 8-K - Current report
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/16

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report